Ursodeoxycholic acid for terbinafine-induced toxic hepatitis.
Agca
Erhan
E
Akcay
Ali
A
Simsek
Halis
H
D000935:Antifungal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000188:drug therapy* / Q000209:etiology*; D002756:Cholagogues and Choleretics / Q000627:therapeutic use*; D002779:Cholestasis / Q000139:chemically induced / Q000188:drug therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D009281:Naphthalenes / Q000009:adverse effects* / Q000627:therapeutic use; D014009:Onychomycosis / Q000188:drug therapy; D000077291:Terbinafine; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use*
D000935:Antifungal Agents; D002756:Cholagogues and Choleretics; D009281:Naphthalenes; D014580:Ursodeoxycholic Acid; D000077291:Terbinafine